Clinical Ink announced that it entered into a collaboration with Tandem Diabetes Care to integrate (AID) data.
MannKind (Nasdaq:MNKD) announced today that the FDA approved its Furoscix (furosemide) on-body infusor for pediatric patients ...
Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback